These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17976734)

  • 21. Nigral burden of alpha-synuclein correlates with striatal dopamine deficit.
    Kovacs GG; Milenkovic IJ; Preusser M; Budka H
    Mov Disord; 2008 Aug; 23(11):1608-12. PubMed ID: 18649394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
    Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
    Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of a new assay for α-synuclein detection in cerebrospinal fluid.
    Førland MG; Öhrfelt A; Oftedal LS; Tysnes OB; Larsen JP; Blennow K; Zetterberg H; Alves G; Lange J
    Clin Chem Lab Med; 2017 Feb; 55(2):254-260. PubMed ID: 27474841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of amyloid-beta 40 in cerebrospinal fluid.
    Verwey NA; Veerhuis R; Twaalfhoven HA; Wouters D; Hoozemans JJ; Bollen YJ; Killestein J; Bibl M; Wiltfang J; Hack CE; Scheltens P; Blankenstein MA
    J Immunol Methods; 2009 Aug; 348(1-2):57-66. PubMed ID: 19576899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
    Koo HJ; Choi MY; Im H
    Biochem Biophys Res Commun; 2009 Aug; 386(1):165-9. PubMed ID: 19501571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-synuclein is a potential biomarker in the serum and CSF of patients with intractable epilepsy.
    Rong H; Jin L; Wei W; Wang X; Xi Z
    Seizure; 2015 Apr; 27():6-9. PubMed ID: 25891920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of electrochemiluminescence assays for highly sensitive and reproducible quantification of α-synuclein in cerebrospinal fluid.
    Kruse N; El-Agnaf OM; Mollenhauer B
    Bioanalysis; 2017 Apr; 9(8):621-630. PubMed ID: 28504552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An enzyme-linked immunosorbent assay (ELISA) for quantification of mouse surfactant protein D (SP-D).
    Hansen S; Schmidt V; Steffensen MA; Jensen PH; Gjerstorff M; Thiel S; Holmskov U
    J Immunol Methods; 2008 Jan; 330(1-2):75-85. PubMed ID: 18078951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection and assessment of alpha-synuclein in Parkinson disease.
    Tsao HH; Huang CG; Wu YR
    Neurochem Int; 2022 Sep; 158():105358. PubMed ID: 35561817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevation of Gas6 protein concentration in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy (CIDP).
    Sainaghi PP; Collimedaglia L; Alciato F; Leone MA; Puta E; Naldi P; Castello L; Monaco F; Avanzi GC
    J Neurol Sci; 2008 Jun; 269(1-2):138-42. PubMed ID: 18279894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain.
    Petzold A; Shaw G
    J Immunol Methods; 2007 Jan; 319(1-2):34-40. PubMed ID: 17140597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. beta-Sheet-breaking peptides inhibit the fibrillation of human alpha-synuclein.
    Kim YS; Lim D; Kim JY; Kang SJ; Kim YH; Im H
    Biochem Biophys Res Commun; 2009 Oct; 387(4):682-7. PubMed ID: 19622344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microarray expression analysis of human dopaminergic neuroblastoma cells after RNA interference of SNCA--a key player in the pathogenesis of Parkinson's disease.
    Häbig K; Walter M; Stappert H; Riess O; Bonin M
    Brain Res; 2009 Feb; 1256():19-33. PubMed ID: 19135032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased levels of elastin-derived peptides in cerebrospinal fluid of patients with lacunar stroke.
    Tzvetanov P; Nicoloff G; Rousseff R; Christova P
    Clin Neurol Neurosurg; 2008 Mar; 110(3):239-44. PubMed ID: 18093726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assay validation and biological variation of serum receptor for advanced glycation end-products.
    Brown LF; Fraser CG
    Ann Clin Biochem; 2008 Sep; 45(Pt 5):518-9. PubMed ID: 18753428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.
    Azeredo da Silveira S; Schneider BL; Cifuentes-Diaz C; Sage D; Abbas-Terki T; Iwatsubo T; Unser M; Aebischer P
    Hum Mol Genet; 2009 Mar; 18(5):872-87. PubMed ID: 19074459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain-derived neurotrophic factor concentrations in the cerebrospinal fluid of patients with Parkinson's disease.
    Salehi Z; Mashayekhi F
    J Clin Neurosci; 2009 Jan; 16(1):90-3. PubMed ID: 19017558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Modelling synucleinopathies in genetically modified animals--successes and failures].
    Ninkina NN; Ustiugov AA; Bukhman VL
    Mol Biol (Mosk); 2008; 42(5):840-55. PubMed ID: 18988533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analytical validation of a highly sensitive microparticle-based immunoassay for the quantitation of IL-13 in human serum using the Erenna immunoassay system.
    St Ledger K; Agee SJ; Kasaian MT; Forlow SB; Durn BL; Minyard J; Lu QA; Todd J; Vesterqvist O; Burczynski ME
    J Immunol Methods; 2009 Oct; 350(1-2):161-70. PubMed ID: 19732777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA; Lin J; Sadiq SA
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.